JD

Joel Drewry

Principal at Versant Ventures

Greater Toronto Area, Canada

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Principal

    2014

    Versant Ventures is a healthcare venture capital firm founded in 1999 with over $4 billion under management and offices in North America and Europe. Roles: Board Director, Dayra Therapeutics Board Director, Fable Therapeutics Board Director, Abdera Therapeutics Board Observer, Firefly Bio Board Observer, Rayze Bio Board Observer, Ventus Therapeutics Board Observer, Nested Therapeutics Board Observer, LENZ Therapeutics Board Observer, Seawolf Therapeutics

2015 - 2016

  • Strategy and Operations Associate

    2015 - 2016

  • Industrial Postdoctoral Fellow - Discovery Team

    2012 - 2014

2008 - 2012

  • Doctoral Student

    2008 - 2012